Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Submissions

  • Online Submissions
  • Author Guidelines
  • Copyright Notice
  • Privacy Statement

Online Submissions

Already have a Username/Password for Journal of Jurnal Komplikasi Anestesi?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

 

1.GENERAL PROVISIONS

a. Article can be either original article or review.

b. Article have never been published in any journal and have not been accepted for publication in other journals.

c. Article is typed in 2 spaces using quarto paper (A4); fonts of Times New Roman size 12; and the right, left, top, bottom margins of 2 cm.

d. Article is typed with one column layout.

e. Article is written in English in accordance with general guidelines.

f. The article does not exceed 4.500 words, including References (excluding abstracts).

g. Article must be accompanied by a cover letter contains of the reason for the article to be published in the Jurnal Komplikasi Anestesi, what is known from the topic discussed, what advantages are added to the article, and the statement from the author that the written article is really original work and does not contain elements of plagiarism.

h. Article is submitted in softcopy using the Microsoft Word application to the OJS Journal website of Jurnal Komplikasi Anestesi (http://www.jurnal.ugm.ac.id/jka). See the checklist submission section before submitting your article.

i. Community service that is planning a scientific publications can apply for Ethical Clearance before community service is held. Original research with community service data that has been going on, can then apply for Ethical Clearance by using secondary data from the community service data. For review article, no Ethical Clearance is required.

j. Please download article template to guide you write your article

 

2.SYSTEMATIC WRITING OF ORIGINAL RESEARCH ARTICLE

a. Title

I. The title consists of 15-20 words.

ii. The author’s name (without an academic degree) is accompanied by affiliation.

iii. The corresponding author's personal information such as mobile numbers, telephone and fax numbers must be clear and valid.

b. Abstract

I. Abstract is written in English.

ii. Abstract consists of 200-300 words that explain the background, methods, results, and conclusions.

iii. Keywords are written in English with 3-5 words.

c. Introduction

I. The target population (community) is highlighted, explaining the context in which the target population takes shelter.

ii. Discussing the facts or phenomena in the target population that are the basis for implementing community empowerment activities.

iii. Things that have been done by other parties in overcoming the problem.

iv. The research objective and target of community empowerment activities are related to problems, challenges or community needs.

d. Methods

I. Describing the method used to solve problems, challenges or problems, answer the research objectives.

ii. Data collection techniques (including sample selection techniques, validity and reliability of data collection tools).

iii. Data analysis technique.

iv. Location, time and duration of activities.

e. Result

I. Relevant documentation with a focus on community empowerment activities.

1. For photos: the minimum resolution is 300 dpi with JPEG extensions (.jpg). Use image processing software to check dpi.

2. For images: scanned with a minimum resolution of 300dpi with JPEG extensions (.jpg). Use image processing software to check dpi.

ii. Results must be presented correctly and accompanied by an explanation without reference to the literature. Original and important findings must be stated. Results must be illustrated with numbers or tables if necessary, but must be kept to a minimum. Detailed discussion, speculation and interpretation of data are not included in the results, but in the discussion section.

f. Discussion

I. The discussion must interpret the findings expressed in the results obtained with the background of existing knowledge. The discussion must highlight what's new. Each assumption must be clearly stated.

ii. Linkages between results and the context of the target population and possible generalizations to other populations.

iii. The advantages and disadvantages of community empowerment activities that are carried out with the conditions of the surrounding community.

g. Conclusion

I. Provide conclusions on the level of achievement of targets for community empowerment activities.

ii. Providing conformity to methods of community empowerment with problems, needs and challenges that exist in the area of community empowerment activities.

iii. Give conclusions about the impact and benefits of community empowerment activities.

iv. Provide advice for further community empowerment.

h. Acknowledgement

I. A separate thank you at the end of the article before the reference, not on the title page and not as a footnote to the title or vice versa.

ii. Acknowledgement list consist of people who provided assistance during community empowerment activities.

iii. Declaration of Conflict of Interest must be clearly written when you (or your company or sponsor) have a financial, commercial, legal, or professional relationship with another organization, or with people who work with them, which can affect your research.

iv. When funding comes from grants available from universities, colleges, or other research institutions, write down the name of the institution or organization that provided the funds.

v. If there are no funders from a university, college, or other research institution, please include the following sentence: This study did not receive specific grants from funding agencies in the public sector, commercial, or non-profit section

I .References

I. References are written based on Vancouver style.

ii. References are listed in numerical order, and in the same order as quoted in the text.

iii. The References only lists references that you have quoted in the text.

iv. Identify references with Arabic numerals (1, 2, 3, 4, 5, 6, 7, 8, 9) as superscripts in the order of appearance.

v. Check details of references to actual sources. The author is responsible for the accuracy and completeness of the references.

vi. Consistent with reference styles throughout the article.

vii. Authors are strongly urged to use a reference manager such as Zotero, Endnote or Mendeley to build their bibliography.

viii. Examples :

1. Standard journal article: Lundmark, Linda. Economic restructuring into Swedish mountain range tourism. Scandinavian Journal of Hospitality and Tourism. 2005; 5 (1): 23–45.

2. Organization as the author: Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in of participants with impaired glucose tolerance. Hypertension. 2002; 40 (5): 679-86.

3. The author's name is not given: Drug-resistance tuberculosis among the foreign-born in Canada. Can Commun Dis Rep. 2005 Feb 15; 31 (4): 46-52. 21st century heart solution may have a sting in the tail. BMJ. 2002; 325 (7537): 184.

4. The author is not in English: Calera Rubio AA, Roel Valdes JM, Casal Lareo A, Gadea Merino R, Rodrigo Cencillo F. Riesgo quimico laboral: elemental para un diagnostico en Espana [Occupational chemical risk: elements for a diagnostic in Spain]. Rev Esp Salud Publica. 2005 Mar-Apr; 79 (2): 283-95.

5. Volume with supplements: Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short-and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002; 42 Suppl 2: S93-9.

6. Isssue with supplement: Crawford M, Mullan J, Vanderveen T. Technology and safe medication administration. J Infusion Nurs. 2005 Mar-Apr; 28 (2 Suppl): 37-41.

7. Volume with section: Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995; 32 (Pt 3): 303-6.

8. Issues with sections: Ahrar K, Madoff DC, Gupta S, et al. Development of a large animal model for lung tumors. J Vasc Radiol Interv. 2002; 13 (9 Pt 1): 923-8.

9. Issue without volume: Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop. 2002; (401): 230-8.

10. Without publication without volume: Keppel K, Pamuk E, Lynch J, et al. The methodological issues in measuring health disparities. Vital Health Stat 2. 2005; (141): 1-16.

11. More than one organization as a writer: American Psychological Association. Publication manual of the American Psychological Association (6th ed.). Washington, DC. 2009

12. Chapter of the book: Ansel HC. Pharmaceutical measurement. 13th. Philadelphia: Lippincott Williams & Wilkins, 2010. Chapter 3: Pharmaceutical measurement; p.35-47.

13. Conference proceedings: Bruhat M, Silva Carvalho JL, Campo R, et al, eds. Proceedings of the 10th Congress of the European Society for Gynecological Endoscopy; 2001 Nov 22-24; Lisbon, Portugal. Bologna (Italy): Monduzzi Editore, International Proceedings Division; 2001. 

 

3.SYSTEMATIC WRITING OF REVIEW

a. Title 

I. Title consists of 15 – 20 words.

ii. The author’s name (without academic degree) is accompanied by affiliation.

iii. The corresponding author’s personal information such as phone number, telephone number and fax number must be clear and valid.

b. Abstract

I. Abstract is written in English.

ii. Abstract consists of 200 – 300 words describing background, methods, results, and conclusions.

iii. Keywords are written in Indonesian and English with 3 – 5 words each.

c. Introduction

I. Discussing about facts or phenomenon that is becoming the basis for the implementation of  community empowerment activites.

ii. Things that have been done by other parties in overcoming the problem.

iii. The research objective and target of community empowerment activities are related to problems, challenges or community needs.

iv. The purpose of the review.

d. Methods

I. Outlines the methods used to resolve the problems, challenges or problems, and answer the purpose of the review. Also, describe the type of review you used (systematic review, scoping review, etc.).

ii. Describe the article collection techniques.

iii. Article analysis technique.

e. Result

Results must be presented with clarity, accuracy, and explanation. Original and important findings must be stated. Results must be illustrated with numbers or tables if necessary, but must be kept to a minimum. Detailed discussion, speculation and interpretation of data are not included in the results, but in the discussion section.

f. Discussion

Describes the advantages and disadvantages of community empowerment activities that are carried out with the conditions of the surrounding community.

g. Conclusion 

I. Providing conformity to methods of community empowerment with problems, needs and challenges that exist in the area of community empowerment activities.

ii. Give conclusions about the impact and benefits of community empowerment activities.

iii. Provide suggestions to community empowerment activities if implemented.

h. Acknowledgement

I. A separate thank you at the end of the article before the reference, not on the title page and not as a footnote to the title or vice versa.

ii. Acknowledgments contains a list of people who provide support, funding from the grants available from the university, college, or other research institutions, by writing the name of the institution or organization providing funds.

iii. Declaration of Conflict of Interest must be clearly written when you (or your company or sponsor) have a financial, commercial, legal, or professional relationship with another organization, or with people who work with them, which can affect your research.

iv. If there are no funding from a university, college, or other research institutions, please include the following sentence: This study did not receive specific grants from funding agencies in the public sector, commercial, or non-profit section

I. References

I. References are written based on Vancouver style.

ii. References are listed in numerical order, and in the same order as quoted in the text.

iii. The references only lists references that you have quoted in the text.

iv. Identify references with Arabic numerals (1, 2, 3, 4, 5, 6, 7, 8, 9) as superscripts in the order of appearance.

v. Check the details of references to actual sources. The author is responsible for the accuracy and completeness of the references.

vi. Consistent with reference styles throughout the article.

vii. Authors are strongly urged to use a reference manager such as Zotero, Endnote or Mendeley to build their bibliography.

viii. Examples:

1. Standard journal article: Lundmark, Linda. Economic restructuring into tourism in the Swedish mountain range. Scandinavian Journal of Hospitality and Tourism. 2005; 5 (1): 23–45.

2. Organization as the author: Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40(5):679-86.

3. The author’s name is not given: Drug-resistance tuberculosis among the foreign-born in Canada. Can Commun Dis Rep. 2005 Feb 15;31(4):46-52. 21st century heart solution may have a sting in the tail. BMJ. 2002;325(7537):184.

4. The author is not in English: Calera Rubio AA, Roel Valdes JM, Casal Lareo A, Gadea Merino R, Rodrigo Cencillo F. Riesgo quimico laboral: elementos para un diagnostico en Espana [Occupational chemical risk: elements for a diagnostic in Spain]. Rev Esp Salud Publica. 2005 Mar-Apr;79(2):283-95.

5. Volume with supplements: Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93-9.

6.I ssued with supplements: Crawford M, Mullan J, Vanderveen T. Technology and safe medication administration. J Infus Nurs. 2005 Mar-Apr;28(2 Suppl):37-41.

7. Volume with sections: Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995;32(Pt 3):303-6.

8. Issued with sections: Ahrar K, Madoff DC, Gupta S, et al. Development of a large animal model for lung tumors. J Vasc Interv Radiol. 2002;13(9 Pt 1):923-8.

9. Issued without volume: Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop. 2002;(401):230-8.

10. Without pubblication without volume : Keppel K, Pamuk E, Lynch J, et al. Methodologic issues in measuring health disparities. Vital Health Stat 2. 2005;(141):1-16.

11. More than one organization as a writer: American Psychological Association. Publication manual of the American Psychological Association (6th ed.). Washington, DC. 2009.

12. Chapter of the book: Ansel HC. Pharmaceutical measurement. 13th ed. Philadelphia: Lippincott Williams & Wilkins, 2010. Chapter 3: Pharmaceutical measurement; p.35-47.

13. Conference proceedings: Bruhat M, Silva Carvalho JL, Campo R, et al, eds. Proceedings of the 10th Congress of the European Society for Gynaecological Endoscopy; 2001 Nov 22-24; Lisbon, Portugal. Bologna (Italy): Monduzzi Editore, International Proceedings Division; 2001.

 

 

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. Article have never been published in any journal and are not in a status that has been accepted for publication in other journals.
  2. Article is submitted in softcopy using the Microsoft Word application.
  3. Articles must be accompanied by a cover letter that contains the reason for the article to be published in the Jurnal Komplikasi Anestesi (JKA), what is already known from the topic discussed, what advantages are added to the article, and the author's statement that the article was written is really the result of original work and does not contain elements of plagiarism.
  4. Abstract is written in English. Abstract consists of 200-300 words and in it describes the background, methods, results, and conclusions. Keywords are written in English with 3-5 words each.
  5. Article is typed in 2 spaces using quarto paper (A4); fonts of Times New Roman size 12; and the right, left, top, bottom margins of 2 cm. Article is typed in a one column layout. Articles do not exceed 4,500 words, including references (excluding abstracts).
  6. Article is written in various scientific in English.
 

Copyright Notice

 

Articles published in JKA are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. You are free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided you give appropriate credit to the original author(s) and JKA, link to the license, indicate if changes were made, and redistribute any derivative work under the same license.

Copyright on articles is held by the journal, with authors required to sign a copyright transfer agreement.

By submitting to JKA, authors grant any third party the right to use their article to the extent provided by the Creative Commons Attribution-ShareAlike 4.0 International License.

 

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

 


e-ISSN: 2615-5818

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.